DJIA 15,318.23 138.38 0.91%
NASDAQ 3,482.18 30.05 0.87%
S&P 500 1,651.81 12.77 0.78%
market minute promo

Eli Lilly & Co.

NYSE: LLY

+ Add to Portfolio

company name or ticker
Company Photos
(Click to zoom)
Working at Eli Lilly & Co.

Medtronic Saga: Corrupt Science, Belated Warning

6/18/2013 by YCharts

The FDA Might Pull This Drug From the Market (and Why It Doesn't Matter)

Two deaths after patients take Eli Lilly's Zyprexa Relprevv.
6/18/2013 by DailyFinance

Is a Type 1 Diabetes Cure Right Around the Corner?

Exciting new research unlocks the root cause of type 1 diabetes.
6/18/2013 by DailyFinance

CryoPort's Game-Changer In Frozen Biological Shipping

6/18/2013 by Seeking Alpha

Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market

6/18/2013 by Trefis

UPDATE 1-FDA probes deaths of two patients on Lilly schizophrenia drug

6/18/2013 by Reuters

J&J studying deaths of two patients on long-acting Zyprexa

6/18/2013 by Reuters

Why MannKind Is Poised to Pull Back

Market-lagging returns could be written in this 2-star stock.
6/18/2013 by DailyFinance

Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market

6/18/2013 by Seeking Alpha

Pharma Stocks: Court Ruling's Real Meaning

6/17/2013 by YCharts
See More Articles...